UCLA study traces Pavlovian response to small cluster of brain cells
Can't see this email? View it online
   
  April 6, 2017  
  Huntington's Disease  
  The latest huntington's disease news from News Medical  
 UCLA study traces Pavlovian response to small cluster of brain cellsUCLA study traces Pavlovian response to small cluster of brain cells
 
In his famous experiment, Russian scientist Ivan Pavlov rang a bell each time he fed his dogs. Soon, the dogs began drooling in anticipation when they heard the bell, even before food appeared.
 
 
 EPFL scientists develop synthetic methods to crack code of Huntington's diseaseEPFL scientists develop synthetic methods to crack code of Huntington's disease
 
Huntington's disease is a neurodegenerative disorder that causes patients to lose their ability to move, speak, and even think. It is caused by a gene mutation that produces an abnormal form of the protein huntingtin, which aggregates and builds up inside neurons of the cortex and striatum.
 
   Research findings could open new avenue to develop treatments for Alzheimer's diseaseResearch findings could open new avenue to develop treatments for Alzheimer's disease
 
Thin parts of the cell membranes of neurons turn out to be particularly vulnerable to a protein that collects in the brain of people with Alzheimer's disease, according to a University of Michigan researcher.
 
   Researchers propose novel theory of how some cancers circumvent killing power of targeted therapiesResearchers propose novel theory of how some cancers circumvent killing power of targeted therapies
 
Nearly 50 years into the "war" on cancer, doctors possess weapons that once would have seemed magical in their tumor-killing specificity.
 
 Horizon 2020 program selects Precision NanoSystems’ NanoAssemblr platform to develop RNA medicines
 
Horizon 2020 program selects Precision NanoSystems’ NanoAssemblr platform to develop RNA medicinesPrecision NanoSystems NanoAssemblr platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project.
 
 
 New EIU report highlights need for more government action to address the psoriasis challenge
 
New EIU report highlights need for more government action to address the psoriasis challengeA new report by the Economist Intelligence Unit (EIU) reveals governments have taken little or no action to improve care for those living with psoriasis, a chronic autoimmune disease of the skin that affects 125 million people worldwide, since the 2014 World Health Organisation Resolution, which called for global action to improve quality of life for those living with the disease.